Latest Ratios: P/E Ratio -0.2x · EV/EBITDA N/A · ROE -97.0%. (2007–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1M | $2M | $4M | $2M | $3M | $7M | $8M | $7M | $23M | — | $95M |
| Enterprise Value | $120672 | $1M | $-715063 | $228774 | $2M | $-2576516 | $7M | $6M | $18M | — | $95M |
| P/E Ratio → | -0.24 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.15 | 0.25 | 0.47 | 0.25 | 0.68 | 57.12 | 55.01 | 105.22 | — | — | — |
| P/B Ratio | 0.27 | 0.46 | 0.56 | 0.36 | 0.67 | 0.69 | 3.76 | 6.31 | 4.34 | — | 62.41 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.12 | -0.09 | 0.03 | 0.43 | -19.67 | 48.10 | 98.21 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.0% | 32.0% | 40.2% | 39.0% | 14.2% | 100.0% | 98.6% | 66.7% | — | — | — |
| Operating Margin | -59.8% | -59.8% | -47.8% | -96.4% | -181.9% | -8074.0% | -4328.2% | -9507.9% | — | — | — |
| Net Profit Margin | -62.5% | -62.5% | -48.4% | -91.2% | -186.4% | -8030.5% | -4343.7% | -8725.4% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -97.0% | -97.0% | -68.6% | -137.6% | -108.0% | -162.7% | -394.5% | -173.3% | -288.2% | -2897.6% | -284.2% |
| ROA | -57.8% | -57.8% | -41.9% | -68.2% | -74.6% | -130.5% | -189.1% | -109.1% | -125.2% | -236.6% | -147.2% |
| ROIC | -135.5% | -135.5% | -106.7% | -151.5% | -287.5% | -838.1% | -541.0% | -1177.6% | — | — | -271.4% |
| ROCE | -85.2% | -85.2% | -64.8% | -126.5% | -96.1% | -151.3% | -281.6% | -171.0% | -249.9% | -3008.0% | -169.6% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.20 | 0.04 | 0.15 | 0.22 | 0.06 | 0.34 | 0.72 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.25 | -0.67 | -0.32 | -0.24 | -0.93 | -0.47 | -0.42 | -0.97 | — | -0.02 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -49.96 | -49.96 | -50.22 | -96.91 | -34.36 | -1167.89 | -878.57 | -1831.33 | -26.95 | -10.55 | -7.19 |
Net cash position: cash ($2M) exceeds total debt ($1M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | 1.87 | 3.03 | 1.71 | 1.45 | 9.42 | 2.71 | 1.46 | 3.75 | 0.63 | 2.40 |
| Quick Ratio | 1.14 | 1.14 | 2.09 | 0.97 | 1.21 | 9.42 | 2.71 | 1.46 | 3.75 | 0.63 | 2.40 |
| Cash Ratio | 0.56 | 0.56 | 1.63 | 0.56 | 0.50 | 8.69 | 1.85 | 0.96 | 3.48 | 0.50 | 0.05 |
| Asset Turnover | — | 0.92 | 0.82 | 0.78 | 0.46 | 0.01 | 0.04 | 0.02 | — | — | — |
| Inventory Turnover | 2.10 | 2.10 | 1.76 | 1.48 | 3.84 | — | — | — | — | — | — |
| Days Sales Outstanding | — | 60.59 | 47.03 | 62.66 | 194.49 | 111.45 | 71.97 | 527.22 | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% |
| Shares Outstanding | — | $3M | $910758 | $318847 | $138989 | $74084 | $27699 | $9996 | $9934 | $0 | $5821 |
Liquidity and dilution risk
Based on reported figures, MYSZ trades at a price-to-sales ratio of 0.15, which suggests the market is heavily discounting the company's software-as-a-service potential due to the persistent negative earnings and the dilutive impact of its retail-heavy revenue mix compared to broader technology sector peers.
The current P/S multiple reflects a market valuation that appears to treat the company as a distressed asset rather than a growth-stage software provider. Investors should note that the absence of a meaningful P/E or EV/EBITDA ratio underscores the lack of positive earning power, making traditional valuation metrics largely inapplicable to the current financial profile.
As reported in financial statements, MYSZ has struggled with consistently negative ROIC, reaching a low of -53.8% in 2025Q4, which indicates that the capital deployed into the business is currently failing to generate any meaningful economic value for shareholders over the observed ten-quarter period.
The inability to achieve positive returns on invested capital suggests that the company's core technology and retail acquisitions have not yet reached the scale required to overcome fixed operational costs. This trend warrants further investigation into whether the current capital allocation strategy is fundamentally flawed or merely in a prolonged investment phase.
According to recent SEC filings, the company's cash conversion cycle has been highly volatile, peaking at 214 days in 2025Q2, which highlights significant inefficiencies in managing inventory and collecting receivables within the Orgad retail subsidiary compared to more streamlined software-only business models.
The high DIO, which reached 279 days in 2025Q2, suggests that inventory is moving slowly, tying up critical liquidity that could otherwise be used to fund R&D. This operational friction appears to be a structural drag on the company's ability to pivot toward a more efficient, high-margin software licensing model.
Based on MYSZ's reported figures, the quick ratio has fluctuated significantly, dropping to 0.76 in 2026Q1, which indicates a tightening liquidity position that leaves the firm increasingly vulnerable to operational shocks or the need for further dilutive financing to maintain its current research and development roadmap.
The decline in the quick ratio suggests that the company's ability to cover short-term obligations without relying on inventory liquidation is diminishing. Investors should monitor this trend closely, as the current cash burn rate may necessitate additional capital raises that could further dilute existing equity holders.
The most commonly misapplied metric for MYSZ is the price-to-sales ratio, which obscures the underlying quality of revenue by failing to distinguish between low-margin retail sales and high-margin software royalties, thereby providing a misleading picture of the company's true earning potential and long-term scalability.
Analysts should instead focus on a segmented revenue analysis that isolates software-as-a-service income from retail product sales to better assess the company's core technological traction. Relying on consolidated P/S ratios ignores the margin dilution caused by the Orgad subsidiary, leading to an inaccurate assessment of the firm's fundamental value.
Includes 30+ ratios · 19 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MYSZ stock.
My Size, Inc.'s current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
My Size, Inc.'s return on equity (ROE) is -97.0%. The historical average is -181.2%.
Based on historical data, My Size, Inc. is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
My Size, Inc. has 32.0% gross margin and -59.8% operating margin.